# Platelet Transfusion and Repeat TEG-PM in Patients With Severe TBI on Antiplatelet Therapy (Repeat TEG-PM)

> **NCT06433622** · — · ENROLLING_BY_INVITATION · sponsor: **Lancaster General Hospital** · enrollment: 225 (estimated)

## Conditions studied

- Traumatic Intracranial Hemorrhage

## Interventions

- **DIAGNOSTIC_TEST:** Repeat Thromboelastography with Platelet Mapping

## Key facts

- **NCT ID:** NCT06433622
- **Lead sponsor:** Lancaster General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-12-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-11
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06433622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06433622, "Platelet Transfusion and Repeat TEG-PM in Patients With Severe TBI on Antiplatelet Therapy (Repeat TEG-PM)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06433622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*